John E Gallina
CIK 1433032 · EVP & Chief Financial Officer · last filed 2026-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$24.30M
Companies
6
Total Filings
37
Lifetime Open-Market Net
-$36.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARAI | Director | 18,202 | $0.25 | $4.5K | $0 | 6 | 2026-07-07 |
| CVS | Director | 582 | $106.72 | $62.1K | $0 | 2 | 2026-05-15 |
| ELV | EVP & Chief Financial Officer | 63,725 | $377.16 | $24.03M | $0 | 1 | 2023-03-03 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Chief Financial Officer | 46,857 | $482.58 | $22.61M | -$24.09M | 9 | 2022-03-03 |
| ANTX | EVP & Chief Financial Officer | 40,510 | $4.93 | $199.9K | -$5.65M | 6 | 2018-03-07 |
| Elevance Health, Inc. (WLP) Delisted | SVP & Chief Accounting Officer | 22,490 | — | — | -$6.56M | 13 | 2014-03-05 |
Recent Filings · Page 4 of 4
37 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-06-05 | Elevance Health, Inc. (WLP) Delisted | Tax (F) | −259 | -$17.2K | EDGAR |
| 2012-04-04 | Elevance Health, Inc. (WLP) Delisted | Tax (F) | −338 | -$24.7K | EDGAR |
| 2012-03-05 | Elevance Health, Inc. (WLP) Delisted | Mixed | +7,714 | -$255.4K | EDGAR |
| 2011-10-05 | Elevance Health, Inc. (WLP) Delisted | Tax (F) | −165 | -$10.3K | EDGAR |
| 2011-09-07 | Elevance Health, Inc. (WLP) Delisted | Tax (F) | −1,010 | -$62.8K | EDGAR |
| 2011-06-03 | Elevance Health, Inc. (WLP) Delisted | Grant (A) | +1,944 | $0 | EDGAR |
| 2008-09-05 | Elevance Health, Inc. (WLP) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
Showing 31–37 of 37
Prev
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.